PREDICT: Prostate Patient Study

Not Applicable

Completed

• Conditions: Prostate cancer; Cancer; Malignant neoplasm of prostate

• Registration Number: ISRCTN28468474
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34493413/ (added 08/12/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-08-31
• Study Completion: 2020-07-30
• Last Update Posted: 3 October 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 156

Inclusion Criteria

1. Men newly diagnosed with primary non-metastatic PCa
2. Men for whom either active surveillance or radical treatment (prostatectomy +/- radiotherapy) are felt to be appropriate by the diagnosing clinician
3. Age 35-80 years
4. Able to understand and sign the written Informed Consent Form

Exclusion Criteria

1. Subject is known to have a condition, which affects their ability to see, read or understand the decision aid
2. Subject is known to have any other condition, which in the opinion of the investigator makes the subject unsuitable for study participation
3. The subject is unable to comprehend English. (PREDICT Prostate is only available in English currently)

Study & Design

• Study Type: Interventional
• Study Design: Not specified